Dechert Advises Pharmakon Advisors on IP Aspects of Loan Agreement with LumiraDx
April 16, 2021
Dechert LLP has advised Pharmakon Advisors LP, the life sciences investment manager of BioPharma Credit PLC, on intellectual property due diligence for a US$300 million definitive senior secured loan agreement with LumiraDx Investment Limited, a UK-based diagnostics technology company. The loan is expected to boost LumiraDx’s diagnostic offerings, which include COVID-19 antigen tests that have been distributed throughout the U.S., Europe and Africa.
The Dechert team that advised Pharmakon Advisors was led by Carl A. Morales, Ph.D. and included partners Tom Rayski and Diane Siegel Danoff, associate Blaine Hackman, Ph.D. and patent agent Todd Macklin, Ph.D.
About Dechert
Dechert is a leading global law firm with 25 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Related Professionals
